“…Calcium channel blockers having 1,4-dihydropyridine (DHP) structure which nifedipine is the prototype and their condensed analogs such as bicyclo (quinoline) and tricyclo (acridine) have vasodilator and antihypertensive effects (Ö zturk et al, 2008;Simsek et al, 2008Simsek et al, , 2004Saraç et al, 2002;Berkan et al, 2002;Carroll et al, 2004a, b;Ashworth et al, 2002). Some DHP derivatives have also potassium channel opener activity (Klöckner and Trieschmann, 1989;Davis-Taber, et al, 2003;Grissmer and Cahalan, 1989;Mannhold, 2004;Gopalakrishnan et al, 2003). Frank and coworkers synthesized 9-(3-nitrophenyl)-3,4,6,7-tetrahydroacridine-1,8-(2H,5H,9H,10H)-dione and showed its potassium channel opener activity (Frank et al 1993).…”